We recently published a list of Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad. In this ...
There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close.
Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...
Gene therapy, which promises a possible cure for rare diseases like sickle cell, is losing early investors to higher-reward ...
In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...
To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as ...
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation ...
The diabetes market is booming, with continuous glucose monitoring (CGM) and GLP-1 drugs leading the charge in innovation and ...
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results